The J.P. Morgan Healthcare Conference may be over, but that doesn’t mean the dealmaking is. Often, deals that took shape at the meeting materialize later in the year, and some recent buzz puts Pfizer and Biogen at the center of potential takeovers. Pfizer is reportedly eyeing a buyout of cardiovascular player Amarin, whose fish-oil-derived lipid drug… Read More »
A complex network of research funding, institutional ties, and personal influence allowed Coca-Cola, through connections with a nonprofit group, to exert substantial influence over obesity science and policy solutions in China, nudging government policy into alignment with the company’s corporate interests, a Harvard study has found. Professor Susan Greenhalgh’s study reveals not just efforts by… Read More »
We live in a world which heavily focuses on external appearances. This has led to an extraordinary amount of beauty products both homemade and for sale. Thanks to the sea of twisted marketing campaigns, celebrity endorsements, photoshopped models and reality TV shows, there is immense pressure on people to have the “perfect look”. We invest a… Read More »